Cutaneous lymphoma is a type of cancer that develops in the lymphocytes (white blood cells), specifically within the skin. They are divided into T-cell lymphomas and B-cell lymphomas.
T-cell lymphoma is the most common and manifests as irritated, red patches that often resemble Eczema. In advanced stages, lymph nodes and organs may be affected, although the condition is usually manageable and not life-threatening.
Specialized Diagnosis & Personalized Treatment
Tailored & Systematic Therapies for High Effectiveness
Combined Therapies for Optimal Management
Long-term disease stability and positive prognosis
B-cell lymphoma is rarer and requires careful diagnosis to confirm that it is limited to the skin. The most common forms of T-cell lymphomas include Mycosis Fungoides and Sézary Syndrome, which appear as red, dry areas on the skin. Most of these are treatable and have good prognosis.
Recommended Therapies
Treatment for cutaneous lymphoma is adapted according to the type, location, and stage of the cancer, considering the patient’s overall health. Treatments are classified as local and systemic.
✓ Local therapies, which include ultraviolet light phototherapy, topical chemotherapy, corticosteroids, retinoids, immunomodulators, and targeted radiation.
✓ Systemic therapies, which include retinoids, targeted drugs, photopheresis, and immunomodulators.
✓ Surgical excision and radiotherapy may be applied, either individually or in combination, for better results.
The combination of therapies can improve the body’s response to treatment and reduce symptoms, especially in advanced stages or in cases where the lymphoma extensively affects the skin.
